APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lisdexamfetamine Dimesylate Capsules

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Lisdexamfetamine Dimesylate Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

27 December 2025192 pages

Choose your research edition.

Industry ResearchLisdexamfetamine Dimesylate Capsules Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Lisdexamfetamine Dimesylate Capsules Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal Lisdexamfetamine Dimesylate Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lisdexamfetamine Dimesylate Capsules Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Lisdexamfetamine Dimesylate Capsules Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Lisdexamfetamine Dimesylate Capsules market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Lisdexamfetamine Dimesylate Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Lisdexamfetamine Dimesylate Capsules include Zhejiang Huahai Pharmaceutical, Sun Pharmaceutical, Takeda Pharmaceutical, Teva Pharmaceutical, Sandoz, Mylan, Mallinckrodt PLC, Lannett and Hikma Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Lisdexamfetamine Dimesylate Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Lisdexamfetamine Dimesylate Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Lisdexamfetamine Dimesylate Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Lisdexamfetamine Dimesylate Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Lisdexamfetamine Dimesylate Capsules Segment by Company

Zhejiang Huahai Pharmaceutical

Sun Pharmaceutical

Takeda Pharmaceutical

Teva Pharmaceutical

Sandoz

Mylan

Mallinckrodt PLC

Lannett

Hikma Pharmaceuticals

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Alkem Laboratories

Lisdexamfetamine Dimesylate Capsules Segment by Type

10mg per Unit

20mg per Unit

30mg per Unit

40mg per Unit

50mg per Unit

60mg per Unit

70mg per Unit

Lisdexamfetamine Dimesylate Capsules Segment by Application

Attention Deficit Hyperactivity Disorder(ADHD)

Bulimia

Other

Lisdexamfetamine Dimesylate Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lisdexamfetamine Dimesylate Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lisdexamfetamine Dimesylate Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lisdexamfetamine Dimesylate Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Lisdexamfetamine Dimesylate Capsules market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Lisdexamfetamine Dimesylate Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Lisdexamfetamine Dimesylate Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Lisdexamfetamine Dimesylate Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Lisdexamfetamine Dimesylate Capsules Industry Trends Table 2. Lisdexamfetamine Dimesylate Capsules Industry Drivers Table 3. Lisdexamfetamine Dimesylate Capsules Industry Opportunities and Challenges Table 4. Lisdexamfetamine Dimesylate Capsules Industry Restraints Table 5. Global Lisdexamfetamine Dimesylate Capsules Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Lisdexamfetamine Dimesylate Capsules Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Manufacturers Table 9. Global Lisdexamfetamine Dimesylate Capsules Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Lisdexamfetamine Dimesylate Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Lisdexamfetamine Dimesylate Capsules Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Lisdexamfetamine Dimesylate Capsules Manufacturers, Product Type & Application Table 13. Global Lisdexamfetamine Dimesylate Capsules Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Lisdexamfetamine Dimesylate Capsules by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 10mg per Unit Table 17. Major Manufacturers of 20mg per Unit Table 18. Major Manufacturers of 30mg per Unit Table 19. Major Manufacturers of 40mg per Unit Table 20. Major Manufacturers of 50mg per Unit Table 21. Major Manufacturers of 60mg per Unit Table 22. Major Manufacturers of 70mg per Unit Table 23. Global Lisdexamfetamine Dimesylate Capsules Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2026) & (K Units) Table 25. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2027-2032) & (K Units) Table 26. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2021-2026) Table 27. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2027-2032) Table 28. Global Lisdexamfetamine Dimesylate Capsules Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 29. Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2026) & (K Units) Table 30. Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2027-2032) & (K Units) Table 31. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2021-2026) Table 32. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2027-2032) Table 33. Major Manufacturers of Attention Deficit Hyperactivity Disorder(ADHD) Table 34. Major Manufacturers of Bulimia Table 35. Major Manufacturers of Other Table 36. Global Lisdexamfetamine Dimesylate Capsules Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2026) & (K Units) Table 38. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2027-2032) & (K Units) Table 39. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2021-2026) Table 40. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2027-2032) Table 41. Global Lisdexamfetamine Dimesylate Capsules Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 42. Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2026) & (K Units) Table 43. Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2027-2032) & (K Units) Table 44. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2021-2026) Table 45. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2027-2032) Table 46. Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 47. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2021-2026) & (K Units) Table 48. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2021-2026) Table 49. Global Lisdexamfetamine Dimesylate Capsules Sales Forecasted by Region (2027-2032) & (K Units) Table 50. Global Lisdexamfetamine Dimesylate Capsules Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Lisdexamfetamine Dimesylate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 52. North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 53. North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032) & (K Units) Table 54. Europe Lisdexamfetamine Dimesylate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 56. Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032) & (K Units) Table 57. Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 58. Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 59. Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032) & (K Units) Table 60. South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 61. South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2026) & (K Units) Table 62. South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country (2027-2032) & (K Units) Table 63. Global Lisdexamfetamine Dimesylate Capsules Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2021-2026) Table 67. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2027-2032) Table 68. Zhejiang Huahai Pharmaceutical Company Information Table 69. Zhejiang Huahai Pharmaceutical Business Overview Table 70. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 72. Zhejiang Huahai Pharmaceutical Recent Development Table 73. Sun Pharmaceutical Company Information Table 74. Sun Pharmaceutical Business Overview Table 75. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 77. Sun Pharmaceutical Recent Development Table 78. Takeda Pharmaceutical Company Information Table 79. Takeda Pharmaceutical Business Overview Table 80. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 82. Takeda Pharmaceutical Recent Development Table 83. Teva Pharmaceutical Company Information Table 84. Teva Pharmaceutical Business Overview Table 85. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 87. Teva Pharmaceutical Recent Development Table 88. Sandoz Company Information Table 89. Sandoz Business Overview Table 90. Sandoz Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 92. Sandoz Recent Development Table 93. Mylan Company Information Table 94. Mylan Business Overview Table 95. Mylan Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 97. Mylan Recent Development Table 98. Mallinckrodt PLC Company Information Table 99. Mallinckrodt PLC Business Overview Table 100. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 102. Mallinckrodt PLC Recent Development Table 103. Lannett Company Information Table 104. Lannett Business Overview Table 105. Lannett Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 107. Lannett Recent Development Table 108. Hikma Pharmaceuticals Company Information Table 109. Hikma Pharmaceuticals Business Overview Table 110. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 112. Hikma Pharmaceuticals Recent Development Table 113. Ascent Pharmaceuticals Company Information Table 114. Ascent Pharmaceuticals Business Overview Table 115. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 117. Ascent Pharmaceuticals Recent Development Table 118. Apotex Company Information Table 119. Apotex Business Overview Table 120. Apotex Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 122. Apotex Recent Development Table 123. Amneal Pharmaceuticals Company Information Table 124. Amneal Pharmaceuticals Business Overview Table 125. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 127. Amneal Pharmaceuticals Recent Development Table 128. Alkem Laboratories Company Information Table 129. Alkem Laboratories Business Overview Table 130. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio Table 132. Alkem Laboratories Recent Development Table 133. Key Raw Materials Table 134. Raw Materials Key Suppliers Table 135. Lisdexamfetamine Dimesylate Capsules Distributors List Table 136. Lisdexamfetamine Dimesylate Capsules Customers List Table 137. Research Programs/Design for This Report Table 138. Authors List of This Report Table 139. Secondary Sources Table 140. Primary Sources List of Figures Figure 1. Lisdexamfetamine Dimesylate Capsules Product Image Figure 2. Global Lisdexamfetamine Dimesylate Capsules Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Lisdexamfetamine Dimesylate Capsules Market Size (2021-2032) & (US$ Million) Figure 4. Global Lisdexamfetamine Dimesylate Capsules Sales (2021-2032) & (K Units) Figure 5. Global Lisdexamfetamine Dimesylate Capsules Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Lisdexamfetamine Dimesylate Capsules Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 10mg per Unit Image Figure 9. 20mg per Unit Image Figure 10. 30mg per Unit Image Figure 11. 40mg per Unit Image Figure 12. 50mg per Unit Image Figure 13. 60mg per Unit Image Figure 14. 70mg per Unit Image Figure 15. Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 16. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 17. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2021-2032) Figure 18. Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 19. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2021-2032) Figure 21. Attention Deficit Hyperactivity Disorder(ADHD) Image Figure 22. Bulimia Image Figure 23. Other Image Figure 24. Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 25. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2021-2032) Figure 27. Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 28. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2021-2032) Figure 30. North America Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 31. North America Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2032) Figure 32. U.S. Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Canada Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Mexico Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Europe Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Europe Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2032) Figure 37. Germany Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 38. France Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 39. U.K. Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Italy Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Netherlands Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2032) Figure 44. China Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Japan Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South Korea Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Southeast Asia Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 48. India Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Australia Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 50. South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2021-2032) Figure 52. Brazil Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South Africa Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Saudi Arabia Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Turkey Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Argentina Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 57. UAE Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Egypt Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 59. Chile Lisdexamfetamine Dimesylate Capsules Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Global Lisdexamfetamine Dimesylate Capsules Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Figure 63. North America Lisdexamfetamine Dimesylate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Figure 65. Europe Lisdexamfetamine Dimesylate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Lisdexamfetamine Dimesylate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Lisdexamfetamine Dimesylate Capsules Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Lisdexamfetamine Dimesylate Capsules Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg per Unit
  • 20mg per Unit
  • 30mg per Unit
  • 40mg per Unit
  • 50mg per Unit
  • 60mg per Unit
  • 70mg per Unit
Applications
  • Attention Deficit Hyperactivity Disorder(ADHD)
  • Bulimia
  • Other
Companies covered
  • Zhejiang Huahai Pharmaceutical
  • Sun Pharmaceutical
  • Takeda Pharmaceutical
  • Teva Pharmaceutical
  • Sandoz
  • Mylan
  • Mallinckrodt PLC
  • Lannett
  • Hikma Pharmaceuticals
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Lisdexamfetamine Dimesylate Capsules Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Lisdexamfetamine Dimesylate Capsules Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Lisdexamfetamine Dimesylate Capsules Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Lisdexamfetamine Dimesylate Capsules Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Lisdexamfetamine Dimesylate Capsules Market Dynamics
  1. 2.1 Lisdexamfetamine Dimesylate Capsules Industry Trends
  2. 2.2 Lisdexamfetamine Dimesylate Capsules Industry Drivers
  3. 2.3 Lisdexamfetamine Dimesylate Capsules Industry Opportunities and Challenges
  4. 2.4 Lisdexamfetamine Dimesylate Capsules Industry Restraints
3 Lisdexamfetamine Dimesylate Capsules Market by Manufacturers
  1. 3.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Manufacturers (2021-2026)
  3. 3.3 Global Lisdexamfetamine Dimesylate Capsules Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Lisdexamfetamine Dimesylate Capsules Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Lisdexamfetamine Dimesylate Capsules Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Lisdexamfetamine Dimesylate Capsules Manufacturers, Product Type & Application
  7. 3.7 Global Lisdexamfetamine Dimesylate Capsules Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Lisdexamfetamine Dimesylate Capsules Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Lisdexamfetamine Dimesylate Capsules Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Lisdexamfetamine Dimesylate Capsules Tier 1, Tier 2, and Tier 3
4 Lisdexamfetamine Dimesylate Capsules Market by Type
  1. 4.1 Lisdexamfetamine Dimesylate Capsules Type Introduction
  2. 4.1.1 10mg per Unit
  3. 4.1.2 20mg per Unit
  4. 4.1.3 30mg per Unit
  5. 4.1.4 40mg per Unit
  6. 4.1.5 50mg per Unit
  7. 4.1.6 60mg per Unit
  8. 4.1.7 70mg per Unit
  9. 4.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Type
  10. 4.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021 VS 2025 VS 2032)
  11. 4.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2021-2032)
  12. 4.2.3 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2021-2032)
  13. 4.3 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type
  14. 4.3.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021 VS 2025 VS 2032)
  15. 4.3.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2021-2032)
  16. 4.3.3 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2021-2032)
5 Lisdexamfetamine Dimesylate Capsules Market by Application
  1. 5.1 Lisdexamfetamine Dimesylate Capsules Application Introduction
  2. 5.1.1 Attention Deficit Hyperactivity Disorder(ADHD)
  3. 5.1.2 Bulimia
  4. 5.1.3 Other
  5. 5.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Application
  6. 5.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2021-2032)
  8. 5.2.3 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2021-2032)
  9. 5.3 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application
  10. 5.3.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2021-2032)
  12. 5.3.3 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2021-2032)
6 Global Lisdexamfetamine Dimesylate Capsules Sales by Region
  1. 6.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2021-2026)
  4. 6.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Lisdexamfetamine Dimesylate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Lisdexamfetamine Dimesylate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region
  1. 7.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region
  2. 7.1.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2021-2026)
  4. 7.1.3 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2027-2032)
  5. 7.1.4 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032)
  8. 7.2.2 North America Lisdexamfetamine Dimesylate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032)
  11. 7.3.2 Europe Lisdexamfetamine Dimesylate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Lisdexamfetamine Dimesylate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zhejiang Huahai Pharmaceutical
  2. 8.1.1 Zhejiang Huahai Pharmaceutical Company Information
  3. 8.1.2 Zhejiang Huahai Pharmaceutical Business Overview
  4. 8.1.3 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  6. 8.1.5 Zhejiang Huahai Pharmaceutical Recent Developments
  7. 8.2 Sun Pharmaceutical
  8. 8.2.1 Sun Pharmaceutical Company Information
  9. 8.2.2 Sun Pharmaceutical Business Overview
  10. 8.2.3 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  12. 8.2.5 Sun Pharmaceutical Recent Developments
  13. 8.3 Takeda Pharmaceutical
  14. 8.3.1 Takeda Pharmaceutical Company Information
  15. 8.3.2 Takeda Pharmaceutical Business Overview
  16. 8.3.3 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  18. 8.3.5 Takeda Pharmaceutical Recent Developments
  19. 8.4 Teva Pharmaceutical
  20. 8.4.1 Teva Pharmaceutical Company Information
  21. 8.4.2 Teva Pharmaceutical Business Overview
  22. 8.4.3 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio
  24. 8.4.5 Teva Pharmaceutical Recent Developments
  25. 8.5 Sandoz
  26. 8.5.1 Sandoz Company Information
  27. 8.5.2 Sandoz Business Overview
  28. 8.5.3 Sandoz Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio
  30. 8.5.5 Sandoz Recent Developments
  31. 8.6 Mylan
  32. 8.6.1 Mylan Company Information
  33. 8.6.2 Mylan Business Overview
  34. 8.6.3 Mylan Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio
  36. 8.6.5 Mylan Recent Developments
  37. 8.7 Mallinckrodt PLC
  38. 8.7.1 Mallinckrodt PLC Company Information
  39. 8.7.2 Mallinckrodt PLC Business Overview
  40. 8.7.3 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio
  42. 8.7.5 Mallinckrodt PLC Recent Developments
  43. 8.8 Lannett
  44. 8.8.1 Lannett Company Information
  45. 8.8.2 Lannett Business Overview
  46. 8.8.3 Lannett Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio
  48. 8.8.5 Lannett Recent Developments
  49. 8.9 Hikma Pharmaceuticals
  50. 8.9.1 Hikma Pharmaceuticals Company Information
  51. 8.9.2 Hikma Pharmaceuticals Business Overview
  52. 8.9.3 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  54. 8.9.5 Hikma Pharmaceuticals Recent Developments
  55. 8.10 Ascent Pharmaceuticals
  56. 8.10.1 Ascent Pharmaceuticals Company Information
  57. 8.10.2 Ascent Pharmaceuticals Business Overview
  58. 8.10.3 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  60. 8.10.5 Ascent Pharmaceuticals Recent Developments
  61. 8.11 Apotex
  62. 8.11.1 Apotex Company Information
  63. 8.11.2 Apotex Business Overview
  64. 8.11.3 Apotex Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio
  66. 8.11.5 Apotex Recent Developments
  67. 8.12 Amneal Pharmaceuticals
  68. 8.12.1 Amneal Pharmaceuticals Company Information
  69. 8.12.2 Amneal Pharmaceuticals Business Overview
  70. 8.12.3 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio
  72. 8.12.5 Amneal Pharmaceuticals Recent Developments
  73. 8.13 Alkem Laboratories
  74. 8.13.1 Alkem Laboratories Company Information
  75. 8.13.2 Alkem Laboratories Business Overview
  76. 8.13.3 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio
  78. 8.13.5 Alkem Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Lisdexamfetamine Dimesylate Capsules Value Chain Analysis
  2. 9.1.1 Lisdexamfetamine Dimesylate Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Lisdexamfetamine Dimesylate Capsules Production Mode & Process
  6. 9.2 Lisdexamfetamine Dimesylate Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Lisdexamfetamine Dimesylate Capsules Distributors
  9. 9.2.3 Lisdexamfetamine Dimesylate Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst